Tokito et al. retrospectively analyzed predictive relevance of PD-L1 expression combined with CD8+ TIL density in 74 stage III NSCLC patients receiving concurrent chemoradiotherapy. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.